New methods for the preparation of the cellular intermediate EAC14.
The cellular intermediate EAC14 was successfully prepared by incubating optimally sensitized sheep erythrocytes (EA) with normal serum diluted in complement diluent buffer containing suitable amounts of inhibitors of EAC142 formation from EAC14 and C2, namely polymyxin E and polymyxin B. EAC14 cells could also be prepared by incubating EA with normal serum diluted in Mg2+ free complement diluent buffer in the presence or absence of sucrose. The cellular intermediates prepared by these methods exhibited characteristic EAC142 formation and decay profiles and were found to be suitable for C2 estimations.
D000818:Animals; D003091:Colistin / Q000494:pharmacology; D003172:Complement C1 / Q000302:isolation & purification*; D003175:Complement C2 / Q000032:analysis*; D003181:Complement C4 / Q000302:isolation & purification*; D003171:Complement Pathway, Classical / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D011112:Polymyxin B / Q000494:pharmacology; D012016:Reference Values; D012756:Sheep
D003172:Complement C1; D003175:Complement C2; D003181:Complement C4; D011112:Polymyxin B; D003091:Colistin